Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
4 Jul 2018
Novel fusion proteins to target PD-L1 in HPV associated cancers
Dr James Gulley - Center for Cancer Research, Washington, USA
4 Jun 2018
Phase I study results of M7824 for patients with HPV associated cancers
Dr Julius Strauss - Center for Cancer Research, Washington, USA
4 Jun 2018
Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cance...
Dr Andrew Epstein and Prof Richard Schilsky
4 Jun 2018
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemothe...
Prof Richard Schilsky & Dr Gianni Bisogno
3 Jun 2018
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
What will we expect from novel therapies for oesophageal and gastric malignancie...
Prof Ramon De Mello - University of Algarve, Faro, Portugal
2 Jun 2018
Biomarkers of pembrolizumab response in head and neck cancer
Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA
25 Apr 2018
Impact of microbiome on head and neck cancers
Dr Young Jun Kim - Vanderbilt-Ingram Cancer Center, Nashville, USA
25 Apr 2018
Editor’s Choice for March 2018
Prof Gordon McVie - Founding Editor, ecancer
29 Mar 2018
A Zimbabwean perspective on radiotherapy in care and training
Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe
22 Nov 2017
